Search Results
Jul 30, 2026, 08:25 ET e& reports 11.6% increase in consolidated revenue to AED 38.1 billion in H1 2026
Highlights for H1 2026H1 2026
More news about: e&
Jul 30, 2026, 08:17 ET e& reports 11.6% increase in consolidated revenue to AED 38.1 billion in H1 2026
Highlights for H1 2026H1 2026
More news about: e&
Jul 30, 2026, 08:17 ET Volition Advances Nu.Q® NETs Platform Towards Commercialization
reassuring."Results show that Nu.Q® H3.1 accurately distinguishes sepsis from non-infectious systemic inflammation, is highly correlated with disease severity, and provides excellent prognostic utility for outcomes such as organ failure and mortality1-4. Nu.Q® H3.1 provides new and additional
More news about: VolitionRx Limited
Jul 30, 2026, 08:15 ET POZYTYWNA OPINIA CHMP OTWIERA DROGĘ DO SZERSZEGO STOSOWANIA LEKU REPATHA® FIRMY AMGEN PRZED WYSTĄPIENIEM PIERWSZEGO ZAWAŁU SERCA LUB UDARU MÓZGU
https://doi.org/10.1161/cir.0000000000001303. MAC: REF-107092Le, H. i in. (2025). Very High Prevalence of Nonoptimally Controlled Traditional Risk Factors at the Onset of Cardiovascular Disease. JACC, Volume 86 (Number
More news about: Amgen
Jul 30, 2026, 08:00 ET Diverging Memory Market Outlook in 2027 as DRAM Supply Remains Tight While NAND Flash Supply Conditions Ease, Says TrendForce
expected to keep supply constrained and prices on an upward trajectory. By contrast, NAND Flash is projected to enter a looser supply environment in 2H27 as new production capacity comes online while consumer electronics demand remains weak, increasing downward pressure on prices.DRAM supply
More news about: TrendForce
Jul 30, 2026, 07:00 ET International Paper Reports Second Quarter 2026 Results
Transaction, integration and other costs/benefits that the Company believes are not reflective of the Company's underlying operations. See notes (a) and (h) of the Consolidated Statement of Operations.(b)
More news about: International Paper
Jul 30, 2026, 06:57 ET AEP Reports Second-Quarter 2026 Earnings, Raises Full-Year Guidance
Tax Effect of Adjustments(h)(6)
More news about: American Electric Power
Jul 30, 2026, 06:53 ET RELEX Delivers Record First Half 2026 Growth
approximately 83% year-over-year (YoY) growth in new contract value (H1) and 28% subscription revenue growth in constant currencies. North America remained a key growth engine during the period, achieving 163% YoY growth in new contract value (H1). Q2 2026 also marked the 76th consecutive quarter of ARR growth,
More news about: RELEX Solutions
Jul 30, 2026, 06:50 ET Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance
0.7Income tax impact of adjustments (h)
More news about: Labcorp Holdings Inc
Jul 30, 2026, 06:30 ET Columbus McKinnon Reports Record Orders and Sales in Q1 FY27; Increases FY27 Guidance
with solid growth at both Legacy CMCO1 and Kito CrosbyBook-to-bill of 1.1x with strong order growth positions CMCO well for H2 FY27Increased cash flow Y/Y reflects benefits of the Kito Crosby Acquisition, synergy achievement and improved margin
More news about: Columbus McKinnon Corporation
Jul 30, 2026, 05:33 ET Beijing Review: Young People from China and the U.S. Get an Inside Look at the Future of Robotics
_id=7227134149436605995https://youtu.be/NiJYk-N5R10?is=EQYDx7_lOl2H3S0G
More news about: Beijing Review
Jul 30, 2026, 05:01 ET Group 1 Agrees to Acquire Hennessy Automobile Dealerships in the Atlanta Market to Advance Proven Cluster Strategy
international trade environment), (g) our relationship with our automobile manufacturers and the willingness of manufacturers to approve future acquisitions, (h) our cost of financing and the availability of credit for consumers, (i) our ability to complete acquisitions and dispositions, including the pending
More news about: Group 1 Automotive, Inc.
Jul 30, 2026, 05:01 ET Group 1 Automotive Reports Second Quarter 2026 Financial Results
international trade environment), (g) our relationship with our automobile manufacturers and the willingness of manufacturers to approve future acquisitions, (h) our cost of financing and the availability of credit for consumers, (i) our ability to complete acquisitions and dispositions, including the pending
More news about: Group 1 Automotive, Inc.
Jul 30, 2026, 02:13 ET Headwolf Launches Three New AI Hardware Lines to Resolve Core Industry Pain Points
ink: https://www.amazon.com/dp/B0H4YB7WT4?th=1About HeadwolfHeadwolf is a global brand specializing in consumer-grade portable AI hardware, with core
More news about: Headwolf
Jul 29, 2026, 21:00 ET LG Energy Solution Releases 2026 Second-Quarter Financial Results
Europe, and a gradual reduction in fixed-cost burden driven by increased ESS production in North America.1H ProgressIn the first half of the year, LG Energy Solution reported revenue of KRW 14.1 trillion, marking a 10.5% year-on-year
More news about: LG Energy Solution
Jul 29, 2026, 19:29 ET Securities Fraud Investigation Into Capricor Therapeutics, Inc. (CAPR) Announced Concerning FDA Review And Advisory Committee Meeting - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Charles H. Linehan at 310-201-9150 or 888-773-9224 or email [email protected]
More news about: Glancy Prongay Wolke & Rotter LLP
Jul 29, 2026, 19:08 ET Motiva S.A. - Results for the 2st quarter of 2026
1H251H26Var.%
More news about: Motiva S.A.
Jul 29, 2026, 16:40 ET Ryerson Reports Second Quarter 2026 Results
1H 20261H 2025
More news about: Ryerson Holding Corporation
Jul 29, 2026, 16:30 ET FMC Corporation reports second quarter 2026 results with Adjusted EBITDA above high end of guidance range and solid cash generation
full year, H2, Q3 and Q4*Percentages are calculated using whole numbers. Minor differences may exist due to rounding. India excluded from 2026 guidance and H2 2025Supplemental
More news about: FMC Corporation
Jul 29, 2026, 16:15 ET GFL Environmental Reports Second Quarter 2026 Results and Raises Full Year 2026 Guidance
payments, (f) transaction costs, (g) acquisition, rebranding and other integration costs (included in cost of sales related to acquisition activity), (h) Founder/CEO remuneration and (i) other. For the three and six months ended June 30, 2026, change in value on Call Option has been added back to EBITDA.
More news about: GFL Environmental Inc.
Jul 29, 2026, 16:05 ET BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE
40Gain on sale of assets, net (h)
More news about: Bausch Health Companies Inc.
Jul 29, 2026, 14:31 ET UMD Smith Redesigns MBA Programs, Reducing Degree Requirements to 48 Credits
Smith MBA Programs homepage.About the University of Maryland's Robert H. Smith School of BusinessThe Robert H. Smith School of Business is an internationally recognized leader in management education and research. One of 12 colleges and
More news about: University of Maryland's Robert H. Smith School of Business
Jul 29, 2026, 14:23 ET Nine-State Cyclospora Outbreak Tied to Taco Bell and Taylor Farms Now at 1,947 Confirmed Illnesses -- and Food Safety Lawyer Bill Marler Says There Is No Way to Wash the Parasite Off
victims of foodborne illness in 1993, when he represented Brianne Kiner, the most seriously injured survivor of the Jack in the Box E. coli O157:H7 outbreak. He founded Food Safety News in 2009 and testifies regularly before Congress on food safety policy.
More news about: Marler Clark, The Food Safety Law Firm
Jul 29, 2026, 11:00 ET bswift Secures Two Spots on Newsweek's 2026 Greatest Workplaces Rankings
employees rate their own workplace experiences."Workplace culture is increasingly measured by the people who experience it every day," said Jennifer H. Cunningham, editor-in-chief of Newsweek. "These rankings give employees a voice and recognize the companies creating workplaces where people feel supported,
More news about: bswift LLC
Jul 29, 2026, 10:31 ET Graves Ophthalmopathy Market Expected to Witness Rapid Expansion at a CAGR of 9% During the Forecast Period (2026-2036), Driven by the Recent Approval of Viridian's LUMVOA and the Launch of Emerging Therapies | DelveInsight
Viridian Therapeutics, Inc., ACELYRIN Inc., Kriya Therapeutics, Tourmaline Bio, Inc., Sinocelltech Ltd., Hoffmann-La Roche, Immunovant Sciences GmbH, H. Lundbeck A/S, Sling Therapeutics, Inc., Lassen Therapeutics Inc., Changchun GeneScience Pharmaceutical Co., Ltd., argenx, Amgen, Minghui Pharmaceutical
More news about: DelveInsight Business Research, LLP